Relmada Therapeutics, Inc. RLMD Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount
Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount at other companies
Other financials
Where this comes from
Reported directly by Relmada Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther.
The official record: Relmada Therapeutics, Inc.’s 10-K, filed March 19, 2026, on SEC EDGAR. View the filing →
Ask your AI about Relmada Therapeutics, Inc.'s effective income tax rate reconciliation, nondeductible expense, other, amount.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Relmada Therapeutics, Inc.'s effective income tax rate reconciliation, nondeductible expense, other, amount?
- Relmada Therapeutics, Inc. (RLMD) reported effective income tax rate reconciliation, nondeductible expense, other, amount of $115.38K in Q4 2025.